JORDAN ATTISHA: Open Payments
NPI 1578048138 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 47 payments from 16 companies in 2025. Trend: 2023 $1,012 · 2024 $772 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $242 |
| ABBVIE INC. | 6 | $231 |
| Lilly USA, LLC | 10 | $150 |
| PFIZER INC. | 5 | $96 |
| Lundbeck LLC | 2 | $56 |
| Astellas Pharma US Inc | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Amgen Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $23 |
Products named: Ozempic, VRAYLAR, REXULTI, JARDIANCE, NURTEC ODT, MOUNJARO, Veozah, QULIPTA.
Industry payments across MI — which companies pay providers there.
